| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| AL Noor Hosp. |
LSE:ANH |
London |
Ordinary Share |
GB00B8HX8Z88 |
ORD 10P |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
0.00 |
0.0% |
892.00 |
0.00 |
00:00:00 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
|
|
|
|
|
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Health Care Equipment & Services
|
288.27
|
53.85
|
44.61
|
17.4
|
7,144
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| - |
O |
0 |
892.00 |
GBX |
Real-Time news about AL Noor Hosp. (London Stock Exchange): 0 recent articles
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
No Trades
| Date | Subject |
|---|
15/10/2015
12:35 | yet another final: NMC will not put in hostile offer Realistically mediclinic tie up is the better option for both--note comment of earnings neutral in RNS.NMC would take out AlNoor and then cost cut like mad... Cheaper for them (NMC) to continue with their own expansion strategyANH is too big and uneconomical, needs to slim down (dependently or independently)IMHO the current offer is very generous
|
09/10/2015
14:15 | gucci: wonder what price NMS will offer
hopefully 1200p
|
12/5/2015
22:16 | futurdoc: Of course Aishahq, ANH is still growing albeit at a slower rate than in previous year and slower than the market expected.
Yes that would be interesting, using their cash pile and making an EPS enhancing acquisition would be exciting. Just how they don't slaught their balance sheet to do so if they do so. I will be surprised if such a deal is done without a CFO though.
We shall see what unfolds.
|
12/5/2015
15:52 | futurdoc: I had been watching this and NMC since Jan, ANH more closely as I felt it was the better company of the two (better margins, debt free) but the share prices since tell a different story!
The director speak has changed from UAE has one of fastest growing healthcare markets etc to we're watching our competitors etc. Revenue growth has slowed from 24% Y on Y(Q1'13 to Q1 14) to 11.9% (Q1'14 to Q1'15) margins are thankfully stable after slipping last year. EPS was downgraded recently from 58p to 54p.
The number of physicians (previously an important KPI) at quarter end wasn't reported. Concerning as this is the past has been a good proxy for growth.
CEO and now CFO have left in the last 12 months. New Chief medical officer too. Large shareholders sold out completely in the last month too.
No wonder the share price has reacted soo poorly. Overall, I'm cautious and I will await the interim numbers before making a decision.
£7.00 (PE 13, 54p EPS) would interest me, as that would provide some margin of safety against further falls. But then again, the forecast EPS could drop further.
We shall see.
|
15/4/2015
16:36 | sparkymoc: LONDON (Alliance News) - Al Noor Hospitals Group PLC Wednesday confirmed Astro II SPV, which is connected to Faisal Belhoul and Khaldoun Haj Hasan, both non-executive directors, sold 23.4 million shares for a total value of GBP216 million through CREST on Tuesday.
The sale represents a price of 923 pence per share.
On Tuesday, Global Capital magazine had reported that Dubai-based Ithmar, a private equity firm, was selling its 20% stake in Al Noor Hospitals and that Deutsche Bank had been hired to sell the shares at 925 pence per share.
Following the transaction, Astro II SPV has no interest in the Abu Dhabi-based company."
So Non-Exceutive Directors are selling huge stakes?
|
14/4/2015
17:36 | mapmagic: Looks like this is the cause for the fall:
"Meanwhile, reports that Ithmar Capital was planning to sell a stake worth £216m in Dubai-based Al Noor sent its shares into the red."
Placing at what price is the question...
|
30/3/2015
06:47 | mapmagic: Super results! Profits, EBITDA and revenue all strongly up and great outlook for the the future. Well done ANH!
|
06/3/2015
06:47 | gohil18: Nice snippet from the Naked Trader yesterday:
I've bought into NMC Health (NMC).
I really like the middle east medcare sector at the moment. There is a massive catalyst for growth in that Dubai is rolling out mandatory healthcare insurance over the next couple of years which should see shares in NMC continue to rise - and also that of Al Noor which I bought last time and have a load of from lower.
The shares don't on the face of it look cheap - but remember the market looks forwards and it is eyeing up the benefits due from mandatory heathcare.
I think both NMC and ANH will boom (boom shake the room). (Tick, tick, tick.. boom...) (that's enough aged dance music references)
|
05/3/2015
12:01 | gohil18: I note how NMC is up over over 15% since its results. NMC is not only more expensive than ANH on a PBT to MCAP basis, they also have debt where NMC has a nice big net cash position. Interestingly, the broker Jeffries cover's both and reiterated and upped their target on NMC after their results. NMC rose more than 7% on that day alone and are hitting new highs.
It's likely Jeffries will do the same for ANH once the results are published, which from the trading update know will be good. So onwards and upwards. Expect at least £12 in the short term back to previous highs, but between £14-16 in a medium time frame from ANH.
|
23/1/2015
19:42 | jeffcranbounre: Al Noor Hospitals is featured in today's ADVFN podcast.
You can listen to the podcast by clicking here> http://bit.ly/ADVFN0114
In today's podcast:
- Technical Analyst and PR at Materinvestor.co.uk Zak Mir chatting and charting Quindell, Gulf Keystone Petroleum, Tesco, Royal Mail, Anite and Blur.
Zak on Twitter is @ZaksTradingCafe
- The micro and macro news
- Plus the broker forecasts
Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below.
Ten Bagger Tuesday
(All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast).
Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below:
Suggest a stock
(Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast).
You can subscribe to this podcast in iTunes by clicking HERE
To follow me on Twitter click HERE
As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions:
Bronze - £50 (normally £73.82/year)
Silver - £145 (normally £173.71/year)
Level 2 - £350 (normally £472.94/year)
Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just CLICK HERE for more information.
Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing.
Justin
|
Al Noor share price data is direct from the London Stock Exchange
PLUS1
